Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Musculoskeletal Health and Arthritis

McMaster University

$100,000.00

Efficacy of a high quality protein leucine-enriched nutraceutical in attenuating inactivity- and hypoenergetic diet-induced muscle loss in older women

EF 2016-17

Résumé
As we age we are more prone to illness and as a result can spend a period of time in hospital. De facto treatment in hospitalization involves bed rest and thus a pronounced reduction in physical activity. At the same time food intake is often reduced and of particular relevance dietary protein intake is reduced. Such hospital-mediated periods of acute inactivity and reduced food intake can have a long-lasting impact on skeletal muscle mass and function. The reduction in skeletal muscle mass and function is significant since older people all suffer from something known as sarcopenia. Sarcopenia describes the slow insipid age-related loss of muscle and strength that can ultimately precipitate disability and necessitate full time institutionalized care. Thus, periods of acute inactivity and inadequate dietary intake transiently accelerate muscle loss that may be only partially reclaimed, if at all. We propose that this scenario is particularly troubling for older women who may be more susceptible than men to inactivity and undernutrition-mediated effects, and who tend to live longer. We hypothesize that such periods of inactivity and low protein intake are, however, potentially treatable by consuming more dietary protein. Regrettably, the amount of protein needed to offset muscle loss in this situation would be substantial and not likely feasible in a number of older persons due to appetite, dysphagia, poor dentition, and/or food choice. Thus, we have invented a small hydrocolloid (gummy) food that contains protein in a concentrated dose and a specific protein component known as leucine that is critical in triggering the growth of new muscle proteins. In this phase 1 trial we propose to expose otherwise health older women to a period of acute inactivity, that we propose mimics a 2 wk period of hospitalization and/or convalescence following hospitalization, and determine whether a novel high protein leucine-containing nutraceutical can offset muscle and function loss.
Programme
Catalyst Grant: Musculoskeletal Health and Arthritis
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
364121
Name
Phillips Stuart M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
MSK Health - Catalyst Grant IMHA
Projecttitle
Efficacy of a high quality protein leucine-enriched nutraceutical in attenuating inactivity- and hypoenergetic diet-induced muscle loss in older women
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Musculoskeletal Health and Arthritis
Keyworddelim
Aging; Atrophy; Disability; Human; Leucine; Muscle Protein Synthesis; Protein; Protein Breakdown; Sarcopenia; Skeletal Muscle
Abstract
As we age we are more prone to illness and as a result can spend a period of time in hospital. De facto treatment in hospitalization involves bed rest and thus a pronounced reduction in physical activity. At the same time food intake is often reduced and of particular relevance dietary protein intake is reduced. Such hospital-mediated periods of acute inactivity and reduced food intake can have a long-lasting impact on skeletal muscle mass and function. The reduction in skeletal muscle mass and function is significant since older people all suffer from something known as sarcopenia. Sarcopenia describes the slow insipid age-related loss of muscle and strength that can ultimately precipitate disability and necessitate full time institutionalized care. Thus, periods of acute inactivity and inadequate dietary intake transiently accelerate muscle loss that may be only partially reclaimed, if at all. We propose that this scenario is particularly troubling for older women who may be more susceptible than men to inactivity and undernutrition-mediated effects, and who tend to live longer. We hypothesize that such periods of inactivity and low protein intake are, however, potentially treatable by consuming more dietary protein. Regrettably, the amount of protein needed to offset muscle loss in this situation would be substantial and not likely feasible in a number of older persons due to appetite, dysphagia, poor dentition, and/or food choice. Thus, we have invented a small hydrocolloid (gummy) food that contains protein in a concentrated dose and a specific protein component known as leucine that is critical in triggering the growth of new muscle proteins. In this phase 1 trial we propose to expose otherwise health older women to a period of acute inactivity, that we propose mimics a 2 wk period of hospitalization and/or convalescence following hospitalization, and determine whether a novel high protein leucine-containing nutraceutical can offset muscle and function loss.
Competitiondate
201701
Approvedterm2
1 yr 0 mth
Pinamesdelim
Phillips, Stuart M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~